 Bradford Smith
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventilator-Induced Lung Injury | 13 | 2023 | 57 | 6.860 |
Why?
| | Positive-Pressure Respiration | 9 | 2022 | 75 | 2.660 |
Why?
| | Respiration, Artificial | 10 | 2023 | 605 | 2.140 |
Why?
| | Lung | 14 | 2023 | 3928 | 2.140 |
Why?
| | Respiratory Mechanics | 8 | 2020 | 65 | 1.740 |
Why?
| | Acute Lung Injury | 5 | 2023 | 280 | 1.740 |
Why?
| | Lung Injury | 4 | 2020 | 214 | 1.320 |
Why?
| | Pulmonary Alveoli | 6 | 2018 | 403 | 1.190 |
Why?
| | Pulmonary Surfactants | 4 | 2018 | 108 | 1.090 |
Why?
| | Models, Biological | 6 | 2020 | 1707 | 1.010 |
Why?
| | Tidal Volume | 7 | 2022 | 84 | 0.970 |
Why?
| | Ventilators, Mechanical | 2 | 2022 | 60 | 0.790 |
Why?
| | Equipment Design | 3 | 2020 | 527 | 0.710 |
Why?
| | Computer Simulation | 10 | 2020 | 947 | 0.680 |
Why?
| | Continuous Positive Airway Pressure | 2 | 2015 | 69 | 0.680 |
Why?
| | Laryngoscopes | 1 | 2020 | 46 | 0.660 |
Why?
| | Bleomycin | 1 | 2018 | 241 | 0.650 |
Why?
| | Laryngoscopy | 1 | 2020 | 109 | 0.640 |
Why?
| | Animals | 22 | 2024 | 34733 | 0.580 |
Why?
| | Pulmonary Atelectasis | | | 14 | NaN |
Why?
| | Pneumonia, Viral | 1 | 2020 | 361 | 0.480 |
Why?
| | Coronavirus Infections | 1 | 2020 | 355 | 0.480 |
Why?
| | Mice | 9 | 2023 | 16585 | 0.470 |
Why?
| | Algorithms | 4 | 2020 | 1632 | 0.450 |
Why?
| | Mice, Inbred BALB C | 5 | 2019 | 1241 | 0.450 |
Why?
| | Pressure | 3 | 2020 | 238 | 0.450 |
Why?
| | Disease Models, Animal | 7 | 2022 | 4016 | 0.420 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 106 | 0.370 |
Why?
| | Complex Mixtures | 1 | 2009 | 12 | 0.340 |
Why?
| | Cigarette Smoking | 2 | 2022 | 90 | 0.330 |
Why?
| | Rats | 5 | 2020 | 5244 | 0.330 |
Why?
| | Microfluidics | 1 | 2009 | 49 | 0.320 |
Why?
| | Respiratory Function Tests | 4 | 2018 | 594 | 0.320 |
Why?
| | Bronchopulmonary Dysplasia | | | 384 | NaN |
Why?
| | Vitamin D | 1 | 2020 | 384 | 0.320 |
Why?
| | Models, Chemical | 1 | 2009 | 263 | 0.300 |
Why?
| | Rats, Sprague-Dawley | 3 | 2015 | 2314 | 0.260 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | | | 70 | NaN |
Why?
| | Tissue Fixation | | | 35 | NaN |
Why?
| | Leukocytes | 2 | 2022 | 301 | 0.220 |
Why?
| | Respiration | 3 | 2019 | 191 | 0.220 |
Why?
| | Respiratory Physiological Phenomena | | | 30 | NaN |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.220 |
Why?
| | Neutrophil Infiltration | 1 | 2023 | 103 | 0.210 |
Why?
| | Transforming Growth Factor beta1 | | | 162 | NaN |
Why?
| | Humans | 15 | 2023 | 129706 | 0.210 |
Why?
| | Lung Compliance | 2 | 2020 | 46 | 0.200 |
Why?
| | Glycocalyx | | | 22 | NaN |
Why?
| | Endoplasmic Reticulum | 1 | 2024 | 256 | 0.190 |
Why?
| | Glycosaminoglycans | | | 85 | NaN |
Why?
| | Pulmonary Medicine | | | 79 | NaN |
Why?
| | Biomechanical Phenomena | 3 | 2019 | 783 | 0.180 |
Why?
| | Lipopolysaccharides | | | 880 | NaN |
Why?
| | Blood-Air Barrier | | | 11 | NaN |
Why?
| | Mice, Inbred C57BL | 3 | 2022 | 5279 | 0.180 |
Why?
| | Proof of Concept Study | 1 | 2020 | 63 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2020 | 20 | 0.170 |
Why?
| | Nonlinear Dynamics | 2 | 2018 | 88 | 0.170 |
Why?
| | Epithelium | | | 313 | NaN |
Why?
| | Needles | 1 | 2020 | 57 | 0.170 |
Why?
| | Models, Anatomic | 1 | 2020 | 94 | 0.170 |
Why?
| | Pulmonary Surfactant-Associated Protein B | 1 | 2019 | 5 | 0.170 |
Why?
| | Pulmonary Ventilation | 1 | 2020 | 77 | 0.170 |
Why?
| | Th17 Cells | 1 | 2020 | 81 | 0.170 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 1 | 2019 | 10 | 0.160 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 81 | 0.160 |
Why?
| | Healthy Volunteers | 1 | 2020 | 206 | 0.160 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 278 | 0.160 |
Why?
| | Hyperoxia | 1 | 2020 | 103 | 0.160 |
Why?
| | Respiratory Tract Infections | | | 373 | NaN |
Why?
| | Vitamin D Deficiency | 1 | 2020 | 179 | 0.150 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2018 | 120 | 0.150 |
Why?
| | Male | 8 | 2020 | 63544 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3054 | 0.140 |
Why?
| | Sensitivity and Specificity | 2 | 2015 | 1849 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 266 | 0.140 |
Why?
| | Down Syndrome | | | 455 | NaN |
Why?
| | Macrophages, Alveolar | 1 | 2020 | 389 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 526 | 0.140 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 644 | 0.130 |
Why?
| | Animals, Newborn | 1 | 2020 | 819 | 0.130 |
Why?
| | Elasticity | 2 | 2015 | 202 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 381 | 0.120 |
Why?
| | Neutrophils | 1 | 2020 | 1205 | 0.120 |
Why?
| | Tensile Strength | 1 | 2015 | 97 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2015 | 123 | 0.120 |
Why?
| | Therapy, Computer-Assisted | 1 | 2015 | 62 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 985 | 0.110 |
Why?
| | Idiopathic Pulmonary Fibrosis | | | 618 | NaN |
Why?
| | Lung Diseases | | | 757 | NaN |
Why?
| | Hypertension, Pulmonary | | | 1884 | NaN |
Why?
| | X-Ray Microtomography | 1 | 2022 | 86 | 0.100 |
Why?
| | Biomedical Engineering | 1 | 2012 | 24 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1526 | 0.090 |
Why?
| | Hydrodynamics | 1 | 2011 | 40 | 0.090 |
Why?
| | Prognosis | 1 | 2015 | 3801 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 643 | 0.090 |
Why?
| | Random Allocation | 2 | 2014 | 353 | 0.080 |
Why?
| | Computer-Aided Design | 1 | 2009 | 41 | 0.080 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 132 | 0.080 |
Why?
| | Rats, Inbred F344 | 1 | 2015 | 251 | 0.070 |
Why?
| | Asthma | 1 | 2020 | 2257 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 6274 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2612 | 0.060 |
Why?
| | Adolescent | 2 | 2020 | 20355 | 0.060 |
Why?
| | Female | 4 | 2020 | 68562 | 0.060 |
Why?
| | Methacholine Chloride | | | 51 | NaN |
Why?
| | Linear Models | 2 | 2018 | 823 | 0.060 |
Why?
| | Cell Size | 1 | 2024 | 87 | 0.060 |
Why?
| | Endotoxins | | | 222 | NaN |
Why?
| | Biology | | | 82 | NaN |
Why?
| | Biophysics | | | 69 | NaN |
Why?
| | Tyrphostins | | | 16 | NaN |
Why?
| | Amphiregulin | | | 25 | NaN |
Why?
| | Biophysical Phenomena | | | 63 | NaN |
Why?
| | Keratin-5 | | | 49 | NaN |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 271 | 0.040 |
Why?
| | Leukosialin | 1 | 2020 | 14 | 0.040 |
Why?
| | Mannose-Binding Lectins | 1 | 2020 | 12 | 0.040 |
Why?
| | Optical Devices | 1 | 2020 | 13 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 10299 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2020 | 69 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 64 | 0.040 |
Why?
| | Surface Tension | 1 | 2019 | 8 | 0.040 |
Why?
| | Acinar Cells | 1 | 2019 | 12 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 102 | 0.040 |
Why?
| | Quinazolines | | | 245 | NaN |
Why?
| | Endothelial Cells | | | 736 | NaN |
Why?
| | Cell Count | 1 | 2020 | 317 | 0.040 |
Why?
| | Doxycycline | 1 | 2019 | 60 | 0.040 |
Why?
| | Mucin-5B | | | 217 | NaN |
Why?
| | Adaptor Proteins, Signal Transducing | | | 395 | NaN |
Why?
| | Air | 1 | 2018 | 37 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 539 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 379 | 0.040 |
Why?
| | ErbB Receptors | | | 601 | NaN |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 194 | 0.040 |
Why?
| | Eosinophils | 1 | 2020 | 324 | 0.040 |
Why?
| | Synchrotrons | 1 | 2017 | 14 | 0.040 |
Why?
| | Tissue Donors | 1 | 2020 | 399 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2022 | 2075 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 242 | 0.030 |
Why?
| | Allergens | 1 | 2020 | 463 | 0.030 |
Why?
| | Predictive Value of Tests | | | 1981 | NaN |
Why?
| | Risk Factors | 1 | 2019 | 9832 | 0.030 |
Why?
| | Fibroblasts | | | 946 | NaN |
Why?
| | Forced Expiratory Flow Rates | | | 15 | NaN |
Why?
| | Sex Factors | | | 1952 | NaN |
Why?
| | Immunohistochemistry | 1 | 2020 | 1700 | 0.030 |
Why?
| | Rabbits | 1 | 2017 | 758 | 0.030 |
Why?
| | Lung Diseases, Interstitial | | | 594 | NaN |
Why?
| | Thoracotomy | | | 78 | NaN |
Why?
| | Airway Resistance | 1 | 2015 | 38 | 0.030 |
Why?
| | Peak Expiratory Flow Rate | 1 | 2014 | 37 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2019 | 479 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2014 | 119 | 0.030 |
Why?
| | Microscopy | | | 141 | NaN |
Why?
| | Models, Animal | | | 370 | NaN |
Why?
| | Models, Cardiovascular | 1 | 2015 | 193 | 0.030 |
Why?
| | RNA, Messenger | | | 2705 | NaN |
Why?
| | Transcription Factors | | | 1636 | NaN |
Why?
| | Mice, Knockout | 1 | 2019 | 2778 | 0.030 |
Why?
| | Genetic Predisposition to Disease | | | 2272 | NaN |
Why?
| | Case-Control Studies | 1 | 2020 | 3363 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 521 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3145 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1507 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2014 | 413 | 0.020 |
Why?
| | Surface Properties | 1 | 2011 | 391 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 342 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2705 | 0.020 |
Why?
| | Signal Transduction | | | 4863 | NaN |
Why?
| | Computational Biology | 1 | 2011 | 588 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2768 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3106 | 0.010 |
Why?
| | Aged | 1 | 2020 | 22113 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 31103 | 0.010 |
Why?
| | Adult | 1 | 2020 | 35596 | 0.010 |
Why?
|
|
Smith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|